Back to Journals » Therapeutics and Clinical Risk Management » Volume 18

Review

Once-Daily Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents Aged 12 Years and Over: A Short Review of Current Clinical Perspectives

       
Total article views   HTML views PDF downloads Totals
9,310 Dovepress* 6,523+ 387 6,910
PubMed Central* 2,787 435 3,222
Totals 9,310 822 10,132
*Since 13 April 2022

View citations on PubMed Central and Google Scholar